Myelofibrosis Program in Pharmaceutical Benefits Scheme (PBS) 012-18051126
Expand allThis document outlines details of PBS-subsidised ruxolitinib for patients with myelofibrosis (MF).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings. Contact a Local Peer Support (LPS) if unsure of how to action an application.
Myelofibrosis quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial |
Written Electronic S85: |
No |
OPA |
Not specified |
Yes |
|
Continuing |
Telephone Electronic S85: |
No |
OPA |
Not specified |
Yes |